SCHEMBL9033095

SCHEMBL9033095

O=C(Nc1ccc(Cl)cn1)NC1CC1c1ccccc1

nearest known ligand 0.67

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
CNR1 P21554 1/20 0.67
L3MBTL1 Q9Y468 3/20 0.56
RAB9A P51151 5/20 0.54
NPC1 O15118 3/20 0.54
NPSR1 Q6W5P4 3/20 0.54
MEN1 O00255 3/20 0.54
KMT2A Q03164 3/20 0.54
MAPT P10636 2/20 0.52
SMN1; SMN2 Q16637 3/20 0.50
MAPK1 P28482 2/20 0.49
IDH1 O75874 1/20 0.49
DEGS1 O15121 1/20 0.48
LMNA P02545 1/20 0.47
TSHR P16473 1/20 0.47
HTT P42858 1/20 0.47
STAT1 P42224 1/20 0.47
PTK2 Q05397 1/20 0.47
FPR1 P21462 1/20 0.46
FPR2 P25090 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6900498 1.00 CNR1 (0.67) CNR1L3MBTL1RAB9ANPC1NPSR1
SCHEMBL9032140 0.86 CNR1 (0.50) CNR1L3MBTL1RAB9ANPC1NPSR1
SCHEMBL6907422 0.86 CNR1 (0.50) CNR1L3MBTL1RAB9ANPC1NPSR1
SCHEMBL6962752 0.85 CNR1 (0.50) CNR1L3MBTL1RAB9ANPC1NPSR1
SCHEMBL6903854 0.85 CNR1 (0.50) CNR1L3MBTL1RAB9ANPC1NPSR1
SCHEMBL6902360 0.84 MEN1 (0.49) CNR1L3MBTL1RAB9ANPC1NPSR1
SCHEMBL9034906 0.84 MEN1 (0.49) CNR1L3MBTL1RAB9ANPC1NPSR1
SCHEMBL6901308 0.84 CNR1 (0.47) CNR1L3MBTL1RAB9ANPC1NPSR1
SCHEMBL9034699 0.84 CNR1 (0.47) CNR1L3MBTL1RAB9ANPC1NPSR1
SCHEMBL9033725 0.83 KMT2A (0.53) CNR1L3MBTL1RAB9ANPC1MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0706514-A1 COMPOUNDS AND METHODS FOR INHIBITION OF HIV AND RELATED VIRUSES MEDIVIR AB (SE) 1996-04-17 EP disclosed
WO-1995006034-A1 COMPOUNDS AND METHODS FOR INHIBITION OF HIV AND RELATED VIRUSES MEDIVIR AB (SE) 1995-03-02 WO disclosed